Stem Cell Therapy & Stroke
Posted by admin on Nov 5, 2008 in Recent Posts | 0 comments
Stem Cell Therapy & Stroke
The sudden onset of stroke is devastating and leads to temporary and/or permanent disability to speech, sensation, memory and motor neuron damage. The damage is caused by a bleeding or blocked cerebral blood vessel leading to local brain damaged areas with loss of neurons and glial cells.
No effective therapy exists and therefore any stem cell treatment that may offer improvement would be greatly welcomed. With the discovery of Mexico stem cell therapy has come new hope.
Although there are niches and reservoirs of stem cells in the adult brain their numbers are not sufficient to restore neurological function. The umbilical cord blood has stem cells that are pluripotent in their ability to be transformed into many precursor cells of various organs in the body including the brain.
Umbilical cord blood stem cells when placed into culture with nerve growth factor, brain neurotrophic factor and nutrients can form precursor progenitor brain stem cells.
Patients with post stroke syndrome (even for many years) can be given intravenous brain stem cells with stem cell therapy, oligodendrocytes to replace myelin and neuron stem cells. These cells will home (migrate) to areas of damaged brain tissue with hopes of stem cell treatment functional recovery.
Stem cell treatment and stem cell therapy abroad at the Biogenetics Institute, offers alternative cancer treatments as well as stem cell treatment for diabetes, lupus, heart disease, Parkinson’s and other disease.
Although there are niches and reservoirs of stem cells in the adult brain their numbers are not sufficient to restore neurological function. The umbilical cord blood has stem cells that are pluripotent in their ability to be transformed into many precursor cells of various organs in the body including the brain.
Stem cell treatment and stem cell therapy abroad at the Biogenetics Institute, offers alternative cancer treatments as well as stem cell treatment for diabetes, lupus, heart disease, Parkinson’s and other disease.
For more details visit:
Embryonic stem cells have the potential to help treat 70 or more diseases, but developing those new therapies will take time. Alan Lewis is president and CEO of Novocell, a La Jolla-based company that has been developing a potential therapy for diabetes. Novocell has a CIRM grant to assemble a team of researchers who will accelerate the time it takes to get that potential therapy to the FDA for clinical trials.
